Terms: = Lung cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
212 results:
1. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/tnfrsf17 axis.
He M; Jiang W; Li X; Liu H; Ren H; Lin Y
BMC Cancer; 2024 Apr; 24(1):505. PubMed ID: 38649856
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer.
Meng M; Liu X; Liang X; Chen X; Li Y
Medicine (Baltimore); 2024 Apr; 103(16):e37836. PubMed ID: 38640325
[TBL] [Abstract] [Full Text] [Related]
3. Albumin-to-D-dimer ratios: A novel prognostic factor for evaluating first-line chemotherapy efficacy in advanced lung adenocarcinoma patients.
Zhang L; Li X; Wang Z; Zhang Z; Zhang L; Liu Z; Zhang L; Wang S; Khorobrykh TV; He M; Xiao J
Neoplasma; 2024 Feb; 71(1):77-87. PubMed ID: 38506032
[TBL] [Abstract] [Full Text] [Related]
4.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract] [Full Text] [Related]
5. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas.
Lennartz M; Benjamin Dünnebier N; Höflmayer D; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Lutz F; Fraune C; Gorbokon N; Luebke AM; Hube-Magg C; Büscheck F; Menz A; Uhlig R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Steurer S; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C
Am J Surg Pathol; 2024 Apr; 48(4):377-386. PubMed ID: 38271200
[TBL] [Abstract] [Full Text] [Related]
6. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Ghilardi G; Fraietta JA; Gerson JN; Van Deerlin VM; Morrissette JJD; Caponetti GC; Paruzzo L; Harris JC; Chong EA; Susanibar Adaniya SP; Svoboda J; Nasta SD; Ugwuanyi OH; Landsburg DJ; Fardella E; Waxman AJ; Chong ER; Patel V; Pajarillo R; Kulikovskaya I; Lieberman DB; Cohen AD; Levine BL; Stadtmauer EA; Frey NV; Vogl DT; Hexner EO; Barta SK; Porter DL; Garfall AL; Schuster SJ; June CH; Ruella M
Nat Med; 2024 Apr; 30(4):984-989. PubMed ID: 38266761
[TBL] [Abstract] [Full Text] [Related]
7. Decomposing the rural-urban differences in depression among multimorbid older patients in India: evidence from a cross-sectional study.
Saha A; Mandal B; Muhammad T; Ali W
BMC Psychiatry; 2024 Jan; 24(1):60. PubMed ID: 38254089
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
Kut E; Menekse S
Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer.
Liu M; Yan G; Li Y; You R; Liu L; Zhang D; Yang G; Dong X; Ding Y; Yan S; You D; Li Z
Cancer Imaging; 2023 Dec; 23(1):116. PubMed ID: 38041154
[TBL] [Abstract] [Full Text] [Related]
10. Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review.
Silva DNM; Vicente LCC; Glória VLP; de Lima Friche AA
BMC Palliat Care; 2023 Oct; 22(1):150. PubMed ID: 37798715
[TBL] [Abstract] [Full Text] [Related]
11. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract] [Full Text] [Related]
12. Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.
Zhao K; Xia C; Qiu M; Yang Z; Cui T; Song T; Li S; Mei H; Zheng Y; Wang H
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16679-16690. PubMed ID: 37725243
[TBL] [Abstract] [Full Text] [Related]
13. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
[TBL] [Abstract] [Full Text] [Related]
14. MiRNA-423 rs6505162 and miRNA-6811 rs2292879 SNP associated with lung cancer in Hainan, China.
Zhou J; Meng C; Li Y; Fu Y; Long W; Huang H; Liu Y; Lyu P; Xiao S
Biosci Rep; 2023 Sep; 43(9):. PubMed ID: 37694278
[TBL] [Abstract] [Full Text] [Related]
15. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
16. Trends in the incidence of pulmonary nodules in chest computed tomography: 10-year results from two Dutch hospitals.
Hendrix W; Rutten M; Hendrix N; van Ginneken B; Schaefer-Prokop C; Scholten ET; Prokop M; Jacobs C
Eur Radiol; 2023 Nov; 33(11):8279-8288. PubMed ID: 37338552
[TBL] [Abstract] [Full Text] [Related]
17. Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPα expression.
Wang Q; Zhang L; Su Z; Li W; Jia Y; Zhang J
Pulm Pharmacol Ther; 2023 Oct; 82():102227. PubMed ID: 37330168
[TBL] [Abstract] [Full Text] [Related]
18. Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non-small cell lung cancer patients.
Tan X; Wang S; Xia H; Chen H; Xu J; Meng D; Wang Z; Li Y; Yang L; Jin Y
Invest New Drugs; 2023 Jun; 41(3):463-472. PubMed ID: 37140694
[TBL] [Abstract] [Full Text] [Related]
19. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F; Hee Park Y; Kim SB; Takano T; Im SA; Borges G; Lima JP; Aksoy S; Gavila Gregori J; De Laurentiis M; Bianchini G; Roylance R; Miyoshi Y; Armstrong A; Sinha R; Ruiz Borrego M; Lim E; Ettl J; Yerushalmi R; Zagouri F; Duhoux FP; Fehm T; Gambhire D; Cathcart J; Wu C; Chu C; Egorov A; Krop I
Lancet; 2023 May; 401(10390):1773-1785. PubMed ID: 37086745
[TBL] [Abstract] [Full Text] [Related]
20. Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.
Wang S; Hu S; Huang S; Su L; Guo Q; Wu B; Ye J; Zhang D; Zhang Y; Zhang W; Wei Y
Medicine (Baltimore); 2023 Feb; 102(6):e32772. PubMed ID: 36820587
[TBL] [Abstract] [Full Text] [Related]
[Next]
